Selection of escape mutant by HLA-C-restricted HIV-1 Pol-specific cytotoxic T lymphocytes carrying strong ability to suppress HIV-1 replication

被引:25
作者
Honda, Kazutaka [1 ]
Zheng, Nan [1 ]
Murakoshi, Hayato [1 ]
Hashimoto, Masao [1 ]
Sakai, Keiko [1 ]
Borghan, Mohamed Ali [1 ,2 ]
Chikata, Takayuki [1 ]
Koyanagi, Madoka [1 ]
Tamura, Yoshiko [1 ]
Gatanaga, Hiroyuki [1 ,3 ]
Oka, Shinichi [1 ,3 ]
Takiguchi, Masafumi [1 ]
机构
[1] Kumamoto Univ, Ctr AIDS Res, Kumamoto 8600811, Japan
[2] Univ Nizwa, Coll Arts & Sci, Dept Biol Sci, Nizwa, Oman
[3] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Shinjuku Ku, Tokyo, Japan
关键词
CTL; Escape mutation; Fitness; HLA-C; HIV infection; IMMUNODEFICIENCY-VIRUS TYPE-1; I DOWN-REGULATION; CELLULAR IMMUNE-RESPONSES; SURFACE EXPRESSION; PRIMARY INFECTION; VIRAL LOAD; NEF; ASSOCIATION; MUTATIONS; BINDING;
D O I
10.1002/eji.201040841
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV-1 mutants escaping from HLA-A-or HLA-B-restricted CTL have been well studied, but those from HLA-C-restricted CTL have not. Therefore we investigated the ability of HLA-C-restricted CTL to select HIV-1 escape mutants. In the present study, we identified two novel HLA-Cw*1202-restricted Pol-specific CTL epitopes (Pol328-9 and Pol463-10). CTL specific for these epitopes were detected in 25-40% of chronically HIV-1-infected HLA-Cw*1202(+) 1 individuals and had strong abilities to kill HIV-1-infected cells and to suppress HIV-1 replication in vitro, suggesting that these CTL may have the ability to effectively control HIV-1 in some HLA-Cw*1202(+) individuals. Sequence analysis of these epitopes showed that a V-to-A substitution at the 9th position (V9A) of Pol 463-10 was significantly associated with the HLA-Cw*1202 allele and that the V9A mutant was slowly selected in the HLA-Cw*1202(+) individuals. Pol 463-10-specific CTL failed both to kill the V9A virus-infected cells and to suppress replication of the V9A mutant. These results indicate that the V9A mutation was selected as an escape mutant by the Pol463-10-specific CTL. The present study strongly suggests that some HLA-C-restricted CTL have a strong ability to suppress HIV-1 replication so that they can select HIV escape mutants as in the case of HLA-A-restricted or HLA-B-restricted CTL.
引用
收藏
页码:97 / 106
页数:10
相关论文
共 43 条
  • [1] Nef interference with HIV-1-specific CTL antiviral activity is epitope specific
    Adnan, Sama
    Balamurugan, Arumugam
    Trocha, Alicja
    Bennett, Michael S.
    Ng, Hwee L.
    Ali, Ayub
    Brander, Christian
    Yang, Otto O.
    [J]. BLOOD, 2006, 108 (10) : 3414 - 3419
  • [2] Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation
    Akari, H
    Arold, S
    Fukumori, T
    Okazaki, T
    Strebel, K
    Adachi, A
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (06) : 2907 - 2912
  • [3] Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
    Allen, TM
    O'Connor, DH
    Jing, PC
    Dzuris, JL
    Mothé, BR
    Vogel, TU
    Dunphy, E
    Liebl, ME
    Emerson, C
    Wilson, N
    Kunstman, KJ
    Wang, XC
    Allison, DB
    Hughes, AL
    Desrosiers, RC
    Altman, JD
    Wolinsky, SM
    Sette, A
    Watkins, DI
    [J]. NATURE, 2000, 407 (6802) : 386 - 390
  • [4] HIV Nef:: Role in pathogenesis and viral fitness
    Arien, Kevin K.
    Verhasselt, Bruno
    [J]. CURRENT HIV RESEARCH, 2008, 6 (03) : 200 - 208
  • [5] Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
    Barouch, DH
    Kunstman, J
    Kuroda, MJ
    Schmitz, JE
    Santra, S
    Peyerl, FW
    Krivulka, GR
    Beaudry, K
    Lifton, MA
    Gorgone, DA
    Montefiori, DC
    Lewis, MG
    Wolinsky, SM
    Letvin, NL
    [J]. NATURE, 2002, 415 (6869) : 335 - 339
  • [6] Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
    Borrow, P
    Lewicki, H
    Wei, XP
    Horwitz, MS
    Peffer, N
    Meyers, H
    Nelson, JA
    Gairin, JE
    Hahn, BH
    Oldstone, MBA
    Shaw, GM
    [J]. NATURE MEDICINE, 1997, 3 (02) : 205 - 211
  • [7] OPTIMAL INFECTIVITY IN-VITRO OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REQUIRES AN INTACT NEF GENE
    CHOWERS, MY
    SPINA, CA
    KWOH, TJ
    FITCH, NJS
    RICHMAN, DD
    GUATELLI, JC
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (05) : 2906 - 2914
  • [8] The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells
    Cohen, GB
    Gandhi, RT
    Davis, DM
    Mandelboim, O
    Chen, BK
    Strominger, JL
    Baltimore, D
    [J]. IMMUNITY, 1999, 10 (06) : 661 - 671
  • [9] HLA-DEPENDENT VARIATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS NEF PROTEIN ALTER PEPTIDE HLA BINDING
    COUILLIN, I
    CONNAN, F
    CULMANNPENCIOLELLI, B
    GOMARD, E
    GUILLET, JG
    CHOPPIN, J
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (03) : 728 - 732
  • [10] Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach
    De Groot, AS
    Jesdale, B
    Martin, W
    Saint Aubin, C
    Sbai, H
    Bosma, A
    Lieberman, J
    Skowron, G
    Mansourati, F
    Mayer, KH
    [J]. VACCINE, 2003, 21 (27-30) : 4486 - 4504